Asker Healthcare Group AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	594	492	360	203	430	467
Depreciation & Amortization	820	752	548	502	341	185
Other Amortization	62	62	60	46	54	45
Loss (Gain) From Sale of Assets	-	-	-	1	-	-
Other Operating Activities	42	15	300	179	118	-108
Change in Accounts Receivable	-123	-87	292	-217	-22	239
Change in Inventory	61	53	-144	21	-12	-181
Change in Other Net Operating Assets	182	41	-189	317	67	-265
Operating Cash Flow	1,638	1,328	1,227	1,052	976	382
Operating Cash Flow Growth	49.05%	8.23%	16.63%	7.79%	155.50%	-
Capital Expenditures	-619	-590	-348	-151	-123	-124
Sale of Property, Plant & Equipment	19	15	-	-	1	-
Cash Acquisitions	-1,666	-2,331	-1,109	-632	-1,738	-719
Investing Cash Flow	-2,267	-2,906	-1,457	-783	-1,860	-843
Short-Term Debt Issued	-	59	126	-	-	-
Long-Term Debt Issued	-	5,098	467	77	902	858
Total Debt Issued	1,053	5,157	593	77	902	858
Long-Term Debt Repaid	-	-4,548	-296	-219	-734	-235
Net Debt Issued (Repaid)	877	609	297	-142	168	623
Issuance of Common Stock	-	1,407	-	63	399	1
Other Financing Activities	-14	9	8	-4	5	-5
Financing Cash Flow	845	2,025	305	-83	572	619
Foreign Exchange Rate Adjustments	-5	-53	24	-5	29	3
Miscellaneous Cash Flow Adjustments	-1	-	-	-1	-	-
Net Cash Flow	210	394	99	180	-283	161
Free Cash Flow	1,019	738	879	901	853	258
Free Cash Flow Growth	36.59%	-16.04%	-2.44%	5.63%	230.62%	-
Free Cash Flow Margin	5.89%	4.40%	5.85%	6.70%	7.28%	2.76%
Free Cash Flow Per Share	2.66	2.00	2.73	3.44	3.30	1.09
Cash Interest Paid	198	201	228	192	95	-
Cash Income Tax Paid	267	337	201	126	100	85
Levered Free Cash Flow	1,020	767.25	478.5	698	400.38	-
Unlevered Free Cash Flow	1,114	899.13	667.25	863	516.63	-
Change in Working Capital	120	7	-41	121	33	-207